Moreover, both NVP-BEZ235 and PP242 inhibited c-Jun phosphorylation and AP-1 activity in RCC cell lines, while Rapamycin only inhibited AP-1 activity but not induced stable inactivation of c-Jun in 786-0 and UOK121 cells. This evidence concerns the gene FOS and renal cell carcinoma.